山东威高集团医用高分子制品股份有限公司（下称“威高股份”，股票代码：01066）于2026年6月18日发布翌日披露报表。公告显示，公司在香港联交所场内回购16.00万股股份，占回购前公司已发行股本约0.0036%。本次回购每股价格介乎3.16港元至3.20港元，总涉资约50.88万港元。
据公告披露，回购完成后，威高股份的已发行股本变动为4,463,057,924股，库存股数增至59,274,400股。公司于2026年5月29日通过本次回购授权，授权可回购股份总数为446,464,632股。截至2026年6月18日，已合计回购1,948,400股，占授权通过当日已发行股本（不包括库存股份）的0.4364%。公司确认已遵守香港联交所主板上市规则及相关法律法规开展本次股份回购。公告由公司秘书黄妙玲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.